Market Overview:
The global urticaria drug market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of urticaria, rising awareness about available treatment options, and growing demand for self-medication. Based on type, the global urticaria drug market is segmented into acute urticaria and chronic urticaria. Acute urticaria is further sub-segmented into physical hives and allergic hives. Chronic hives are further sub-segmented into autoimmune diseases and idiopathic diseases. Based on application, the global market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others (clinics/physicians’ offices). Geographically, the global market is segmented into North America, Latin America, Europe Asia Pacific ,and Middle East & Africa . Some of the key players operating in this market are GlaxoSmithKline plc (U.K.), Pfizer Inc.(U.S.), Novartis AG (Switzerland), Sanofi SA(France), AstraZeneca plc (U.K.), Teva Pharmaceutical Industries Ltd.(Israel), Johnson & Johnson Services Inc.(U.S.), Merck & Co., Inc.(U.S.).
Product Definition:
Urticaria Drug is a histamine blocker used to treat and prevent hives.
Acute Urticaria:
Acute urticaria is a type of urticaria that occurs with symptoms such as itchy skin, swelling of the tongue and hives. It may also lead to wheals (wheal and bubble), which are raised lesions filled with fluid. Wheals usually last for less than 24 hours; however, in some cases they may persist for up to 3 days.
Wheals can range from 1 cm to 10 cm in diameter.
Chronic Urticaria:
Chronic urticaria is a type of urticaria that continues for more than 6 months. The condition may occur in any age group but mostly occurs during the adolescents and adults. It affects both men and women equally.
Application Insights:
The others segment held the largest share of the global market in 2017. This segment includes chronic idiopathic angeder, atopic dermatitis, and urticaria associated with pregnancy. The application of acute urticaria drugs is limited to hospital pharmacies due to their high cost which is unaffordable for other segments.
The hospital pharmacies segment is expected to grow at a lucrative rate over the forecast period owing to increasing prevalence of target diseases such as atopic dermatitis and chronic idiopathic angeder which are associated with increased use of anti-inflammatory drugs such as aspirin, ibuprofen among others in hospitals. As a result, demand for cheaper generic products will drive this application segment over the forecast period thereby impacting overall market growth negatively.
Regional Analysis:
North America dominated the global market in 2017. The presence of key pharmaceutical companies, availability of branded drugs, and high healthcare expenditure are some factors responsible for its large share. Moreover, increasing prevalence of chronic diseases such as diabetes is also expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising geriatric population and improving economic conditions in emerging countries such as China and India. Furthermore, an increase in online purchasing due to lack of knowledge about dosage forms will boost revenue generation over this period. Increasing cases of urticaria among patients undergoing kidney transplantation are also expected to fuel demand for these drugs during the forecast period (2018-2030).
Growth Factors:
- Increasing incidence of urticaria
- Growing awareness about urticaria and its treatment options
- Rising demand for better and more effective therapies for urticaria
- Technological advancements in the field of urticaria drug development
- Growing number of clinical studies on new drugs for the treatment of urticaria
Scope Of The Report
Report Attributes
Report Details
Report Title
Urticaria Drug Market Research Report
By Type
Acute Urticaria, Chronic Urticaria
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
By Companies
Johnson and Johnson Services, Amneal Pharmaceuticals, Pfizer, Taro Pharmaceutical Industries Novartis AG, Akorn, Teva Pharmaceutical Industries, Genentech, Xolair
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Urticaria Drug Market Report Segments:
The global Urticaria Drug market is segmented on the basis of:
Types
Acute Urticaria, Chronic Urticaria
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson and Johnson Services
- Amneal Pharmaceuticals
- Pfizer
- Taro Pharmaceutical Industries Novartis AG
- Akorn
- Teva Pharmaceutical Industries
- Genentech
- Xolair
Highlights of The Urticaria Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Acute Urticaria
- Chronic Urticaria
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Urticaria Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Urticaria drug is a medication used to treat urticaria, a skin condition that causes hives. Urticaria drugs can be prescribed by your doctor to help relieve the symptoms of urticaria, such as itching and swelling.
Some of the key players operating in the urticaria drug market are Johnson and Johnson Services, Amneal Pharmaceuticals, Pfizer, Taro Pharmaceutical Industries Novartis AG, Akorn, Teva Pharmaceutical Industries, Genentech, Xolair.
The urticaria drug market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Urticaria Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Urticaria Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Urticaria Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Urticaria Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Urticaria Drug Market Size & Forecast, 2020-2028
4.5.1 Urticaria Drug Market Size and Y-o-Y Growth
4.5.2 Urticaria Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Acute Urticaria
5.2.2 Chronic Urticaria
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Urticaria Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Urticaria Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Acute Urticaria
9.6.2 Chronic Urticaria
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Acute Urticaria
10.6.2 Chronic Urticaria
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Acute Urticaria
11.6.2 Chronic Urticaria
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Acute Urticaria
12.6.2 Chronic Urticaria
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Acute Urticaria
13.6.2 Chronic Urticaria
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Urticaria Drug Market: Competitive Dashboard
14.2 Global Urticaria Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson and Johnson Services
14.3.2 Amneal Pharmaceuticals
14.3.3 Pfizer
14.3.4 Taro Pharmaceutical Industries Novartis AG
14.3.5 Akorn
14.3.6 Teva Pharmaceutical Industries
14.3.7 Genentech
14.3.8 Xolair
